Mineralys Therapeutics Inc.

MLYS | NASDAQ

Price Alert Chart Builder DCF Calculator

$29.09

+$0.78 (+2.76%)

Sep 22, 2026, 1:45 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Quarter Period Ending	Q2 2026 Jun 29, 2026	Q1 2026 Mar 30, 2026	Q4 2025 Dec 30, 2025	Q3 2025 Sep 29, 2025	Q2 2025 Jun 29, 2025	Q1 2025 Mar 30, 2025	Q4 2024 Dec 30, 2024	Q3 2024 Sep 29, 2024	Q2 2024 Jun 29, 2024	Q1 2024 Mar 30, 2024	Q4 2023 Dec 30, 2023	Q3 2023 Sep 29, 2023	Q2 2023 Jun 29, 2023	Q1 2023 Mar 30, 2023	Q4 2022 Dec 30, 2022	Q3 2022 Sep 29, 2022	Q2 2022 Jun 29, 2022	Q1 2022 Mar 30, 2022	Q4 2021 Dec 30, 2021
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	6K	n/a	15K	n/a	n/a	n/a	n/a	n/a	8K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	n/a	-6K	n/a	-15K	n/a	n/a	n/a	n/a	n/a	-8K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Income	-246.04M	-45.34M	-38.28M	-41.13M	-46.75M	-44.45M	-51.77M	-60.11M	-45.17M	-35.36M	-27.71M	-26.27M	-15.74M	-14.94M	-10.01M	-7.42M	-6.48M	-7.57M	-7.08M
Interest Income	4.96M	6M	6.05M	4.2M	3.47M	2.24M	2.81M	3.77M	4.15M	3.85M	3.32M	3.51M	3.59M	2.33M	935K	741K	n/a	n/a	n/a
Pretax Income	-241.07M	-39.34M	-32.23M	-36.93M	-43.27M	-42.21M	-48.95M	-56.34M	-41.01M	-31.51M	-24.39M	-22.76M	-12.14M	-12.61M	-9.07M	-6.68M	-6.48M	-7.57M	-7.08M
Net Income	-241.07M	-39.34M	-32.23M	-36.93M	-43.27M	-42.21M	-48.95M	-56.34M	-41.01M	-31.51M	-24.39M	-22.76M	-12.14M	-12.61M	-9.07M	-6.68M	-6.48M	-7.57M	-7.08M
Selling & General & Admin	24.66M	20.98M	13.88M	9.68M	8.47M	6.57M	7.2M	6.12M	5.9M	4.6M	4.03M	3.77M	3.85M	2.65M	2.19M	1.36M	884K	791K	467K
Research & Development	221.38M	24.37M	24.4M	31.45M	38.28M	37.88M	44.57M	53.99M	39.27M	30.75M	23.69M	22.5M	11.88M	12.29M	7.82M	6.06M	5.6M	6.78M	6.62M
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	246.04M	45.34M	38.28M	41.12M	46.75M	44.45M	51.77M	60.11M	45.17M	35.35M	27.71M	26.27M	15.74M	14.94M	10.01M	7.42M	6.48M	7.57M	7.08M
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-8K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	246.04M	45.34M	38.28M	41.13M	46.75M	44.45M	51.77M	60.11M	45.17M	35.36M	27.71M	26.27M	15.74M	14.94M	10.01M	7.42M	6.48M	7.57M	7.08M
Income Tax Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Shares Outstanding (Basic)	84.73M	82.83M	80.55M	70.59M	65.45M	53.16M	49.96M	49.82M	49.36M	44.9M	40.09M	39.93M	39.76M	24.76M	5.21M	5.18M	5.14M	5.12M	5.06M
Shares Outstanding (Diluted)	84.73M	82.83M	80.55M	70.59M	65.45M	53.16M	49.96M	49.82M	49.36M	44.9M	40.09M	39.93M	39.75M	24.76M	5.21M	5.18M	5.15M	5.12M	5.06M
EPS (Basic)	-2.85	-0.47	-0.40	-0.52	-0.66	-0.79	-0.98	-1.13	-0.83	-0.70	-0.61	-0.57	-0.31	-0.51	-1.74	-1.29	-1.26	-1.48	-1.40
EPS (Diluted)	-2.85	-0.47	-0.40	-0.52	-0.66	-0.79	-0.98	-1.13	-0.83	-0.70	-0.61	-0.57	-0.31	-0.51	-1.74	-1.29	-1.26	-1.48	-1.40
EBITDA	-241.07M	-39.33M	-32.22M	-36.92M	-43.26M	-42.2M	-48.93M	-56.33M	-41.01M	-31.5M	-24.35M	-22.76M	-12.14M	-12.61M	935K	745K	n/a	n/a	n/a
EBIT	-241.07M	-39.34M	-32.23M	-36.93M	-43.27M	-42.21M	-48.95M	-56.34M	-41.01M	-31.51M	-24.39M	-22.76M	-12.14M	-12.61M	-9.07M	-6.68M	-6.48M	-7.57M	-7.08M
Depreciation & Amortization	5K	6K	13K	15K	16K	15K	15K	11K	9K	8K	43.81K	n/a	n/a	n/a	10.01M	7.42M	6.48M	7.57M	7.08M